news10nbc23h
FDA approves JournaVX, a non-opioid pain relief option for adults
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
New non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
Hosted on MSN19h
Can FDA-approved Journavx Put An End To Death From Opioids?
This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on ...
fingerlakes14h
FDA approves non-addictive alternative to opioids: How does it work?
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
Daily Jang8h
FDA approves first novel non-opioid painkiller in decades
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
FDA approves new non-addictive painkiller alternative to opioids
The drug is called Journavx and doctors believe it has no potential for addiction and dependence.
Daijiworld19h
US FDA approves painkillers designed to eliminate risk of addiction associated with opioids
US federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The US Food and Drug ...
KAAL TV19h
FDA approves new pain medication intended to reduce likelihood of addiction
The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.
Pharmabiz16h
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...